ERYTHROCIN STEARATE Drug Patent Profile
✉ Email this page to a colleague
When do Erythrocin Stearate patents expire, and when can generic versions of Erythrocin Stearate launch?
Erythrocin Stearate is a drug marketed by Arbor Pharms Llc and is included in one NDA.
The generic ingredient in ERYTHROCIN STEARATE is erythromycin stearate. There are one hundred and three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for ERYTHROCIN STEARATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ERYTHROCIN STEARATE at DailyMed |
Pharmacology for ERYTHROCIN STEARATE
Drug Class | Macrolide Antimicrobial Macrolide |
Physiological Effect | Decreased Sebaceous Gland Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ERYTHROCIN STEARATE
US Patents and Regulatory Information for ERYTHROCIN STEARATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | ERYTHROCIN STEARATE | erythromycin stearate | TABLET;ORAL | 060359-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Arbor Pharms Llc | ERYTHROCIN STEARATE | erythromycin stearate | TABLET;ORAL | 060359-001 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Arbor Pharms Llc | ERYTHROCIN STEARATE | erythromycin stearate | TABLET;ORAL | 060359-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |